ꯅꯍꯥꯛꯅꯥ ꯗꯥꯏꯑꯦꯕꯦꯇꯤꯖ ꯂꯩ, ꯃꯔꯝ ꯑꯗꯨꯅꯥ ꯅꯍꯥꯛꯀꯤ ꯗꯣꯛꯇꯔꯅꯥ ꯅꯍꯥꯀꯄꯨ ꯏꯅꯁꯨꯂꯤꯟ ꯗꯦꯒ꯭ꯂꯨꯗꯦꯛ ꯀꯧꯕꯥ ꯏꯅꯖꯦꯀꯁꯟ ꯑꯃꯥ ꯄꯤꯔꯀꯄꯥ ꯌꯥꯏ꯫ ꯑꯗꯣꯝꯅꯥ ꯃꯁꯤ ꯇ꯭ꯔꯦꯁꯤꯕꯥ ꯍꯥꯌꯕꯥ ꯕ꯭ꯔꯥꯟꯗ ꯅꯦꯝ ꯑꯁꯤꯅꯥ ꯈꯉꯂꯃꯒꯅꯤ꯫ ꯃꯁꯤ ꯃꯇꯝ ꯁꯥꯡꯅꯥ ꯊꯕꯛ ꯇꯧꯕꯥ, ꯆꯥꯎꯔꯥꯛꯅꯥ ꯅꯨꯃꯤꯠ ꯈꯨꯗꯤꯡꯒꯤ ꯊꯕꯛ ꯇꯧꯕꯥ ꯌꯥꯝꯅꯥ ꯑꯅꯧꯕꯥ ꯃꯈꯂꯒꯤ ꯏꯅꯁꯨꯂꯤꯟ ꯑꯃꯅꯤ꯫ ꯑꯗꯨꯅꯥ ꯉꯁꯤꯗꯤ ꯃꯁꯤ ꯁꯤꯖꯤꯟꯅꯕꯒꯤ ꯃꯇꯥꯡꯗꯥ ꯑꯗꯣꯝꯅꯥ ꯈꯉꯒꯗꯕꯥ ꯃꯔꯨꯑꯣꯏꯕꯥ ꯋꯥꯐꯝ ꯈꯔꯥ ꯈꯟꯅꯔꯁꯤ꯫
ꯏꯅꯁꯨꯂꯤꯟ ꯗꯦꯒ꯭ꯂꯨꯗꯦꯛ ꯍꯥꯌꯕꯁꯤ ꯇꯁꯦꯡꯅꯥ ꯀꯔꯤꯅꯣ?
ꯌꯥꯝꯅꯥ ꯂꯥꯏꯅꯥ ꯍꯥꯌꯔꯕꯗꯥ, ꯏꯅꯁꯨꯂꯤꯟ ꯗꯦꯒ꯭ꯂꯨꯗꯦꯛ ꯑꯁꯤ ꯗꯥꯏꯑꯦꯕꯦꯇꯤꯖ ꯀꯟꯠꯔꯣꯜ ꯇꯧꯕꯗꯥ ꯁꯤꯖꯤꯟꯅꯕꯥ ꯍꯤꯗꯥꯛ ꯑꯃꯅꯤ꯫ ꯃꯁꯤ ꯃꯇꯝ ꯁꯥꯡꯅꯥ ꯊꯕꯛ ꯇꯧꯕꯥ ꯏꯅꯁꯨꯂꯤꯟ ꯑꯃꯅꯤ꯫ ꯃꯁꯤꯅꯥ ꯇꯥꯀꯄꯗꯤ ꯏꯅꯖꯦꯀꯁꯟ ꯑꯃꯈꯛꯇꯒꯤ ꯃꯇꯨꯡꯗꯥ, ꯃꯁꯤꯅꯥ ꯅꯍꯥꯛꯀꯤ ꯍꯀꯆꯥꯡꯗꯥ ꯃꯊꯧ ꯇꯥꯕꯥ ꯏꯅꯁꯨꯂꯤꯅꯒꯤ ꯆꯥꯡ ꯑꯗꯨ ꯄꯨꯡ ꯀꯌꯥ ꯂꯦꯡꯗꯅꯥ ꯊꯝꯕꯥ ꯉꯝꯃꯤ꯫ ꯃꯁꯤꯅꯥ ꯅꯍꯥꯛꯀꯤ ꯏꯗꯥ ꯌꯥꯎꯔꯤꯕꯥ ꯆꯤꯅꯤ (ꯒ꯭ꯂꯨꯀꯣꯖ)ꯒꯤ ꯆꯥꯡ ꯍꯟꯊꯍꯜꯂꯤ꯫
ꯅꯤꯡꯁꯤꯡꯕꯤꯌꯨ, ꯇꯤꯀꯥ ꯑꯁꯤ ꯈꯛꯇꯅꯥ ꯃꯇꯤꯛ ꯆꯥꯗꯦ꯫ ꯃꯍꯧꯁꯥꯅꯥ, ꯂꯥꯌꯦꯡ ꯑꯁꯤꯒꯥ ꯂꯣꯌꯅꯅꯥ , ꯃꯇꯤꯛ ꯆꯥꯕꯥ ꯗꯥꯏꯠ ꯑꯃꯁꯨꯡ ꯑꯦꯛꯁꯔꯁꯥꯏꯖ ꯇꯧꯕꯁꯨ ꯌꯥꯝꯅꯥ ꯃꯔꯨꯑꯣꯏ꯫
ꯍꯤꯗꯥꯛ ꯑꯁꯤ ꯍꯧꯗ꯭ꯔꯤꯉꯩꯗꯥ ꯅꯍꯥꯛꯀꯤ ꯗꯣꯛꯇꯔꯗꯥ ꯍꯥꯌꯒꯗꯕꯥ ꯋꯥꯐꯃꯁꯤꯡ꯫
ꯇꯤꯀꯥ ꯑꯁꯤ ꯍꯧꯗ꯭ꯔꯤꯉꯩꯒꯤ ꯃꯃꯥꯡꯗꯥ, ꯅꯍꯥꯛꯀꯤ ꯍꯀꯁꯦꯂꯒꯤ ꯐꯤꯚꯃꯒꯤ ꯃꯇꯥꯡꯗꯥ ꯅꯍꯥꯛꯀꯤ ꯗꯣꯛꯇꯔꯗꯥ ꯈꯪꯍꯅꯕꯥ ꯍꯥꯌꯕꯁꯤ ꯌꯥꯝꯅꯥ ꯃꯔꯨꯑꯣꯏ, ꯃꯔꯃꯗꯤ ꯃꯁꯤꯅꯥ ꯅꯍꯥꯀꯄꯨ ꯄꯤꯒꯗꯕꯥ ꯗꯣꯖ ꯑꯃꯁꯨꯡ ꯏꯅꯁ꯭ꯠꯔꯛꯁꯅꯁꯤꯡ ꯑꯗꯨ ꯂꯦꯄꯀꯅꯤ꯫
| ꯅꯈꯣꯌꯒꯤ ꯐꯤꯚꯝ꯫ | ꯗꯣꯛꯇꯔꯗꯥ ꯍꯥꯌꯕꯥ ꯑꯁꯤ ꯀꯔꯤꯒꯤ ꯃꯔꯨ ꯑꯣꯏꯔꯤꯕꯅꯣ ? |
|---|---|
| ꯕ꯭ꯂꯗ ꯁꯨꯒꯔ ꯍꯟꯊꯔꯀꯄꯒꯤ ꯆꯥꯡ ꯅꯥꯏꯅꯥ ꯊꯣꯀꯄꯥ ꯑꯦꯄꯤꯁꯣꯗꯁꯤꯡ꯫ | ꯏꯅꯁꯨꯂꯤꯅꯒꯤ ꯗꯣꯖꯁꯤꯡꯅꯥ ꯍꯥꯏꯄꯣꯒ꯭ꯂꯥꯏꯁꯦꯃꯤꯌꯥꯒꯤ ꯔꯤꯁ꯭ꯛ ꯑꯁꯤ ꯃꯈꯥ ꯇꯥꯅꯥ ꯍꯦꯅꯒꯠꯍꯅꯕꯥ ꯉꯝꯃꯤ, ꯃꯔꯝ ꯑꯗꯨꯅꯥ ꯆꯦꯀꯁꯤꯅꯒꯗꯕꯅꯤ꯫ |
| ꯃꯤꯠꯀꯤ ꯂꯥꯌꯅꯥ ꯅꯠꯠꯔꯒꯥ ꯃꯤꯠ ꯎꯗꯕꯥ꯫ | ꯆꯤꯅꯤꯒꯤ ꯆꯥꯡꯗꯥ ꯑꯍꯣꯡꯕꯥ ꯂꯥꯀꯄꯅꯥ ꯃꯤꯠꯀꯤ ꯂꯥꯌꯅꯥ ꯈꯔꯗꯥ ꯁꯣꯀꯍꯅꯕꯥ ꯌꯥꯏ꯫ |
| ꯀꯤꯗꯅꯤꯒꯤ ꯂꯥꯌꯅꯥ꯫ | ꯀꯤꯗꯅꯤꯁꯤꯡꯅꯥ ꯃꯑꯣꯡ ꯆꯨꯝꯅꯥ ꯊꯕꯛ ꯇꯧꯗꯕꯥ ꯃꯇꯃꯗꯥ, ꯍꯀꯆꯥꯡꯗꯒꯤ ꯏꯅꯁꯨꯂꯤꯟ ꯂꯧꯊꯣꯀꯄꯒꯤ ꯃꯑꯣꯡ ꯑꯁꯤ ꯍꯣꯡꯂꯀꯄꯥ ꯌꯥꯏ, ꯑꯃꯁꯨꯡ ꯗꯣꯖ ꯑꯗꯨ ꯁꯦꯃꯗꯣꯛ-ꯁꯦꯃꯖꯤꯟ ꯇꯧꯕꯥ ꯃꯊꯧ ꯇꯥꯕꯥ ꯌꯥꯏ꯫ |
| ꯂꯤꯚꯔꯒꯤ ꯂꯥꯌꯅꯥ꯫ | ꯂꯤꯚꯔ ꯑꯁꯤꯁꯨ ꯏꯅꯁꯨꯂꯤꯟ ꯐꯉ꯭ꯀꯁꯅꯗꯥ ꯁꯔꯨꯛ ꯌꯥꯕꯅꯥ ꯃꯔꯝ ꯑꯣꯏꯗꯨꯅꯥ ꯗꯣꯛꯇꯔꯅꯥ ꯃꯁꯤꯒꯤ ꯃꯇꯥꯡꯗꯥ ꯈꯪꯖꯤꯅꯒꯗꯕꯅꯤ꯫ |
| ꯏꯅꯁꯨꯂꯤꯟ ꯅꯠꯠꯔꯒꯥ ꯑꯇꯩ ꯍꯤꯗꯥꯛ-ꯂꯥꯡꯊꯀꯁꯤꯡ ꯅꯠꯠꯔꯒꯥ ꯆꯤꯟꯖꯥꯀꯁꯤꯡꯗꯥ ꯑꯦꯂꯥꯔꯖꯤ ꯂꯩꯕꯥ꯫ | ꯃꯁꯤ ꯌꯥꯝꯅꯥ ꯁꯥꯊꯤꯕꯥ ꯑꯦꯂꯥꯔꯖꯤꯒꯤ ꯔꯤꯑꯦꯛꯁꯅꯁꯤꯡ ꯊꯤꯡꯅꯕꯒꯤꯗꯃꯛ ꯌꯥꯝꯅꯥ ꯃꯔꯨꯑꯣꯏ꯫ |
| ꯀꯔꯤꯒꯨꯝꯕꯥ ꯅꯍꯥꯛꯅꯥ ꯃꯤꯔꯣꯜꯂꯤꯕꯥ, ꯃꯤꯔꯣꯅꯕꯥ ꯍꯣꯠꯅꯔꯤꯕꯥ ꯅꯠꯠꯔꯒꯥ ꯈꯣꯝꯂꯥꯡ ꯄꯤꯊꯀꯄꯥ ꯃꯃꯥ ꯑꯃꯥ ꯑꯣꯏꯔꯕꯗꯤ꯫ | ꯃꯤꯔꯣꯜꯂꯤꯉꯩ ꯑꯃꯁꯨꯡ ꯈꯣꯝꯂꯥꯡ ꯄꯤꯊꯀꯄꯥ ꯃꯇꯃꯗꯥ ꯏꯅꯁꯨꯂꯤꯟ ꯑꯁꯤ ꯍꯣꯡꯗꯣꯀꯄꯥ ꯃꯊꯧ ꯇꯥꯏ, ꯃꯔꯝ ꯑꯗꯨꯅꯥ ꯃꯁꯤꯒꯤ ꯃꯇꯥꯡꯗꯥ ꯅꯍꯥꯛꯀꯤ ꯗꯣꯛꯇꯔꯒꯥ ꯋꯥꯔꯤ ꯁꯥꯅꯕꯥ ꯍꯥꯌꯕꯁꯤ ꯌꯥꯝꯅꯥ ꯃꯔꯨꯑꯣꯏ꯫ |
ꯃꯁꯤꯒꯤ ꯚꯦꯛꯁꯤꯟ ꯑꯁꯤ ꯃꯇꯧ ꯀꯔꯝꯅꯥ ꯇꯁꯦꯡꯅꯥ ꯁꯤꯖꯤꯟꯅꯕꯒꯦ?
ꯃꯁꯤꯒꯤ ꯏꯅꯖꯦꯀꯁꯟ ꯑꯁꯤ ꯈꯣꯡꯒꯤ ꯃꯈꯥꯗꯥ ꯄꯤꯔꯤ (subcutaneous injection)꯫ ꯅꯍꯥꯛꯀꯤ ꯗꯣꯛꯇꯔ ꯅꯠꯠꯔꯒꯥ ꯗꯥꯏꯑꯦꯕꯦꯇꯤꯖ ꯀ꯭ꯂꯤꯅꯤꯛ ꯅꯔꯁꯅꯥ ꯅꯍꯥꯀꯄꯨ ꯃꯇꯧ ꯀꯔꯝꯅꯥ ꯄꯤꯒꯗꯒꯦ ꯍꯥꯌꯕꯗꯨ ꯆꯨꯝꯅꯥ ꯇꯥꯛꯀꯅꯤ꯫
- ꯑꯀꯛꯅꯕꯥ ꯗꯣꯖ ꯑꯗꯨ ꯁꯤꯖꯤꯟꯅꯧ꯫ ꯅꯍꯥꯛꯀꯤ ꯗꯣꯛꯇꯔꯅꯥ ꯍꯥꯌꯔꯀꯄꯗꯒꯤ ꯍꯦꯟꯅꯥ ꯀꯩꯗꯧꯉꯩꯗꯥ ꯂꯧꯔꯣꯏꯗꯕꯅꯤ꯫
- ꯏꯅꯁꯨꯂꯤꯅꯒꯤ ꯃꯑꯣꯡ-ꯃꯇꯧ ꯑꯗꯨ ꯌꯦꯡꯎ꯫ ꯍꯤꯗꯥꯛ ꯑꯁꯤ ꯏꯁꯤꯡꯒꯨꯝꯅꯥ ꯃꯌꯦꯛ ꯁꯦꯡꯕꯥ ꯑꯃꯁꯨꯡ ꯃꯆꯨ ꯂꯩꯇꯕꯥ ꯑꯣꯏꯒꯗꯕꯅꯤ꯫ ꯀꯔꯤꯒꯨꯝꯕꯥ ꯃꯗꯨ ꯅꯣꯡꯖꯨ-ꯅꯨꯡꯁꯥ ꯈꯥꯛꯇꯅꯥ ꯂꯩꯔꯕꯗꯤ, ꯃꯗꯨ ꯇꯔꯨ-ꯇꯅꯥꯟꯅꯥ ꯂꯩꯔꯕꯗꯤ, ꯃꯆꯨ ꯁꯪꯂꯕꯥ ꯅꯠꯠꯔꯒꯥ ꯃꯗꯨꯗꯥ ꯄꯣꯠꯁꯛ ꯑꯃꯠꯇꯥ ꯂꯩꯔꯕꯗꯤ ꯁꯤꯖꯤꯟꯅꯒꯅꯨ꯫
- ꯑꯇꯣꯞꯄꯥ ꯏꯅꯁꯨꯂꯤꯅꯁꯤꯡꯒꯥ ꯂꯣꯌꯅꯅꯥ ꯃꯤꯛꯁ ꯇꯧꯔꯣꯏꯗꯕꯅꯤ꯫ ꯏꯅꯁꯨꯂꯤꯟ ꯗꯦꯒ꯭ꯂꯨꯗꯦꯛ ꯃꯈꯜ ꯑꯁꯤ ꯑꯇꯣꯞꯄꯥ ꯃꯈꯂꯒꯤ ꯏꯅꯁꯨꯂꯤꯅꯁꯤꯡꯒꯥ ꯆꯞ ꯃꯥꯟꯅꯕꯥ ꯁꯤꯔꯤꯟꯖꯗꯥ ꯌꯥꯎꯍꯅꯕꯥ ꯑꯁꯤ ꯑꯀꯅꯕꯥ ꯃꯑꯣꯡꯗꯥ ꯑꯊꯤꯡꯕꯥ ꯊꯝꯂꯤ꯫
- ꯀꯔꯤꯒꯨꯝꯕꯥ ꯃꯁꯤ ꯏꯅꯁꯨꯂꯤꯟ ꯄꯦꯟ ꯑꯣꯏꯔꯕꯗꯤ: ꯁꯤꯖꯤꯟꯅꯗ꯭ꯔꯤꯉꯩ ꯃꯃꯥꯡꯗꯥ ꯃꯄꯥꯅꯒꯤ ꯅꯤꯗꯜ ꯀꯚꯔ ꯑꯗꯨ ꯅꯤꯗꯜ ꯑꯗꯨꯗꯒꯤ ꯂꯧꯊꯣꯀꯄꯥ ꯀꯥꯎꯒꯅꯨ꯫
- ꯁꯤꯖꯤꯟꯅꯔꯕꯥ ꯅꯤꯗꯂꯁꯤꯡ: ꯃꯈꯣꯌ ꯑꯁꯤ ꯌꯥꯝꯅꯥ ꯆꯦꯀꯁꯤꯟꯅꯥ ꯂꯧꯊꯣꯛꯀꯗꯕꯅꯤ꯫ ꯁꯤꯖꯤꯟꯅꯔꯕꯥ ꯅꯤꯗꯜ ꯑꯃꯁꯨꯡ ꯁꯤꯔꯤꯟꯖꯁꯤꯡ ꯑꯗꯨ ꯁꯥꯔꯄꯁ ꯀꯟꯇꯦꯅꯔ ꯑꯃꯗꯥ ꯊꯝꯃꯨ꯫ ꯃꯈꯣꯌꯗꯨ ꯀꯩꯗꯧꯉꯩꯗꯥ ꯊꯣꯡꯅꯥꯎꯗꯥ ꯊꯥꯗꯣꯛꯂꯣꯏꯗꯕꯅꯤ꯫ ꯀꯔꯤꯒꯨꯝꯕꯥ ꯅꯍꯥꯛꯅꯥ ꯂꯩꯠꯔꯕꯗꯤ, ꯅꯍꯥꯛꯀꯤ ꯗꯣꯛꯇꯔꯗꯥ ꯃꯇꯧ ꯀꯔꯝꯅꯥ ꯑꯃꯥ ꯂꯧꯒꯗꯒꯦ ꯍꯥꯌꯅꯥ ꯍꯪꯕꯤꯌꯨ꯫
ꯀꯔꯤꯒꯨꯝꯕꯥ ꯍꯤꯗꯥꯛ-ꯂꯥꯡꯊꯛꯀꯤ ꯗꯣꯖ ꯑꯗꯨ ꯍꯦꯅꯒꯠꯂꯛꯂꯕꯗꯤ ꯀꯔꯤ ꯇꯧꯒꯗꯒꯦ?
ꯀꯔꯤꯒꯨꯝꯕꯥ ꯅꯍꯥꯛꯅꯥ ꯍꯤꯗꯥꯛ-ꯂꯥꯡꯊꯛ ꯌꯥꯝꯅꯥ ꯊꯀꯈ꯭ꯔꯦ ꯍꯥꯌꯅꯥ ꯈꯜꯂꯕꯗꯤ, ꯋꯥꯈꯜ ꯅꯨꯡꯉꯥꯏꯇꯕꯥ ꯐꯥꯎꯒꯅꯨ꯫ ꯈꯨꯗꯛꯇꯥ ꯀꯣꯂꯝꯕꯣ ꯅꯦꯁ꯭ꯅꯦꯜ ꯍꯣꯁ꯭ꯄꯤꯇꯥꯂꯗꯥ ꯂꯩꯕꯥ ꯅꯦꯁ꯭ꯅꯦꯜ ꯄꯣꯏꯖꯅꯁ ꯏꯅꯐꯣꯔꯃꯦꯁꯟ ꯁꯦꯟꯇꯔꯗꯥ ꯐꯣꯟ ꯇꯧꯕꯤꯌꯨ . ꯅꯠꯠꯔꯒꯥ ꯈ꯭ꯕꯥꯏꯗꯒꯤ ꯅꯀꯄꯥ ꯍꯣꯁ꯭ꯄꯤꯇꯥꯂꯒꯤ ꯏꯃꯔꯖꯦꯟꯁꯤ ꯇ꯭ꯔꯤꯇꯃꯦꯟꯇ ꯌꯨꯅꯤꯠ (ETU)ꯗꯥ ꯆꯠꯂꯨ꯫
ꯀꯔꯤꯒꯨꯝꯕꯥ ꯑꯩꯅꯥ ꯍꯤꯗꯥꯛ-ꯂꯥꯡꯊꯛꯀꯤ ꯗꯣꯖ ꯑꯃꯥ ꯁꯣꯟꯊꯔꯕꯗꯤ ꯀꯔꯤ ꯇꯧꯒꯅꯤ?
- ꯃꯄꯨꯡ-ꯃꯔꯩ ꯐꯥꯔꯕꯁꯤꯡꯒꯤ ꯑꯣꯏꯅꯗꯤ: ꯀꯔꯤꯒꯨꯝꯕꯥ ꯅꯍꯥꯛꯅꯥ ꯗꯣꯖ ꯑꯃꯥ ꯃꯥꯡꯈꯤꯕꯥ ꯇꯥꯔꯕꯗꯤ, ꯅꯍꯥꯛꯅꯥ ꯅꯤꯡꯁꯤꯡꯂꯀꯄꯥ ꯃꯇꯃꯗꯥ ꯇꯤꯀꯥ ꯑꯗꯨ ꯂꯧꯊꯣꯀꯎ꯫ ꯑꯗꯨꯕꯨ ꯅꯍꯥꯛꯀꯤ ꯃꯊꯪꯒꯤ ꯗꯣꯖꯒꯤ ꯃꯔꯛꯇꯥ ꯌꯥꯃꯗ꯭ꯔꯕꯗꯥ ꯄꯨꯡ 8ꯒꯤ ꯑꯔꯥꯞꯄꯥ ꯂꯩꯒꯗꯕꯅꯤ꯫ꯀꯩꯗꯧꯉꯩꯗꯥ ꯗꯣꯖ ꯑꯅꯤ ꯑꯃꯨꯛ ꯍꯟꯅꯥ ꯂꯧꯔꯣꯏꯗꯕꯅꯤ꯫
- ꯑꯉꯥꯡꯁꯤꯡ ꯑꯃꯁꯨꯡ ꯅꯍꯥ ꯑꯣꯏꯔꯤꯕꯥ ꯑꯍꯂꯁꯤꯡꯒꯤ ꯑꯣꯏꯅꯗꯤ: ꯀꯔꯤꯒꯨꯝꯕꯥ ꯅꯍꯥꯛꯅꯥ ꯑꯦꯄꯣꯏꯟꯇꯃꯦꯟꯇ ꯑꯃꯥ ꯂꯧꯕꯥ ꯉꯃꯗ꯭ꯔꯕꯗꯤ ꯀꯔꯤ ꯇꯧꯒꯗꯒꯦ ꯍꯥꯌꯕꯒꯤ ꯄ꯭ꯂꯥꯟ ꯑꯃꯥ ꯅꯍꯥꯛꯀꯤ ꯗꯣꯛꯇꯔꯅꯥ ꯄꯤꯒꯅꯤ꯫ ꯊꯧꯔꯥꯡ ꯑꯗꯨ ꯑꯀꯛꯅꯅꯥ ꯏꯅꯒꯗꯕꯅꯤ꯫
ꯍꯤꯗꯥꯛ ꯑꯁꯤꯒꯥ ꯃꯔꯤ ꯂꯩꯅꯕꯥ ꯑꯇꯩ ꯄꯣꯠꯁꯀꯁꯤꯡ꯫
ꯅꯍꯥꯛꯅꯥ ꯂꯧꯔꯤꯕꯥ ꯍꯤꯗꯥꯛ-ꯂꯥꯡꯊꯛ ꯄꯨꯝꯅꯃꯛꯀꯤ ꯃꯇꯥꯡꯗꯥ ꯅꯍꯥꯛꯀꯤ ꯗꯣꯛꯇꯔꯗꯥ ꯈꯪꯍꯅꯕꯥ ꯍꯥꯌꯕꯁꯤ ꯌꯥꯝꯅꯥ ꯃꯔꯨꯑꯣꯏ, ꯄ꯭ꯔꯦꯁ꯭ꯛꯔꯤꯄꯁꯟ ꯍꯤꯗꯥꯛ-ꯂꯥꯡꯊꯀꯁꯤꯡ ꯈꯛꯇꯥ ꯅꯠꯇꯅꯥ, ꯑꯣꯚꯔ-ꯗꯤ-ꯀꯎꯟꯇꯔ ꯄꯦꯟ ꯔꯤꯂꯤꯚꯔꯁꯤꯡ, ꯚꯤꯇꯥꯃꯤꯅꯁꯤꯡ ꯑꯃꯁꯨꯡ ꯍꯔꯕꯦꯜ ꯁꯞꯂꯤꯃꯦꯟꯇꯁꯤꯡꯁꯨ ꯈꯪꯍꯅꯕꯥ ꯍꯥꯌꯕꯁꯤ ꯌꯥꯝꯅꯥ ꯃꯔꯨꯑꯣꯏ, ꯃꯔꯃꯗꯤ ꯃꯁꯤꯒꯤ ꯃꯅꯨꯡꯗꯥ ꯈꯔꯗꯤ ꯏꯅꯁꯨꯂꯤꯅꯒꯤ ꯊꯕꯛ ꯇꯧꯕꯒꯤ ꯃꯑꯣꯡꯗꯥ ꯁꯣꯀꯍꯅꯕꯥ ꯌꯥꯏ꯫
ꯃꯈꯥꯗꯥ ꯑꯁꯤꯒꯨꯝꯕꯥ ꯋꯥꯐꯝ ꯈꯔꯥ ꯌꯥꯑꯣꯔꯤ:
- ꯌꯨ : ꯌꯨ ꯊꯀꯄꯅꯥ ꯕ꯭ꯂꯗ ꯁꯨꯒꯔꯒꯤ ꯆꯥꯡ ꯍꯟꯊꯍꯅꯕꯥ ꯅꯠꯠꯔꯒꯥ ꯃꯁꯥ ꯃꯊꯟꯇꯥ ꯍꯦꯅꯒꯠꯍꯅꯕꯥ ꯌꯥꯏ꯫
- ꯑꯇꯣꯞꯄꯥ ꯗꯥꯏꯑꯦꯕꯦꯇꯤꯖꯒꯤ ꯍꯤꯗꯥꯀꯁꯤꯡ: ꯍꯤꯗꯥꯛ-ꯂꯥꯡꯊꯀꯁꯤꯡ ꯑꯁꯤꯒꯥ ꯂꯣꯌꯅꯅꯥ ꯕ꯭ꯂꯗ ꯁꯨꯒꯔ ꯅꯦꯝꯕꯥ (ꯍꯥꯏꯄꯣꯒ꯭ꯂꯥꯏꯁꯦꯃꯤꯌꯥ)ꯒꯤ ꯔꯤꯁ꯭ꯛ ꯍꯦꯅꯒꯠꯂꯀꯏ꯫
- ꯍꯥꯌ ꯕ꯭ꯂꯗ ꯄ꯭ꯔꯦꯁꯔꯒꯤ ꯍꯤꯗꯥꯛ-ꯂꯥꯡꯊꯛ ꯈꯔꯗꯤ (Beta-blockers): ꯃꯁꯤꯅꯥ ꯕ꯭ꯂꯗ ꯁꯨꯒꯔ ꯅꯦꯝꯕꯥ ꯂꯥꯏꯑꯣꯡꯁꯤꯡ (ꯈꯨꯗꯝ ꯑꯣꯏꯅꯥ, ꯁꯣꯀꯄꯥ, ꯍꯥꯔꯠ ꯔꯦꯠ ꯍꯦꯅꯒꯠꯂꯀꯄꯥ) ꯑꯁꯤ ꯃꯥꯁ꯭ꯛ ꯇꯧꯕꯥ ꯉꯝꯃꯤ, ꯃꯔꯝ ꯑꯗꯨꯅꯥ ꯅꯍꯥꯛꯅꯥ ꯈꯪꯗꯅꯥ ꯕ꯭ꯂꯗ ꯁꯨꯒꯔ ꯅꯦꯝꯕꯥ ꯊꯦꯡꯅꯔꯀꯄꯥ ꯌꯥꯏ꯫
- ꯄꯦꯏꯅꯀꯤꯂꯥꯔ (NSAIDs): ꯏꯕꯨꯞꯔꯣꯐꯦꯟ ꯑꯃꯁꯨꯡ ꯅꯦꯞꯔꯣꯛꯁꯦꯅꯒꯨꯝꯕꯥ ꯍꯤꯗꯥꯀꯁꯤꯡ꯫
- ꯁ꯭ꯇꯦꯔꯣꯏꯗꯁꯤꯡ: ꯄ꯭ꯔꯦꯗꯅꯤꯁꯣꯅꯒꯨꯝꯕꯥ ꯍꯤꯗꯥꯀꯁꯤꯡꯅꯥ ꯕ꯭ꯂꯗ ꯁꯨꯒꯔꯒꯤ ꯆꯥꯡ ꯍꯦꯅꯒꯠꯍꯅꯕꯥ ꯉꯝꯃꯤ꯫
- ꯑꯦꯖꯃꯥ, ꯀꯣꯛ ꯆꯤꯀꯄꯥ ꯑꯃꯁꯨꯡ ꯀꯣꯛ ꯅꯣꯟꯖꯕꯒꯤ ꯍꯤꯗꯥꯛ ꯈꯔꯗꯤ꯫
- ꯃꯩꯈꯨ ꯊꯥꯗꯣꯀꯄꯥ꯫
ꯂꯤꯁ꯭ꯠ ꯑꯁꯤ ꯃꯄꯨꯡ ꯐꯥꯗ꯭ꯔꯤ, ꯃꯔꯝ ꯑꯗꯨꯅꯥ ꯅꯍꯥꯛꯅꯥ ꯂꯧꯔꯤꯕꯥ ꯄꯨꯝꯅꯃꯛ ꯑꯗꯨ ꯅꯍꯥꯛꯀꯤ ꯗꯣꯛꯇꯔꯗꯥ ꯁꯣꯌꯗꯅꯥ ꯈꯪꯍꯅꯕꯤꯌꯨ꯫
ꯍꯤꯗꯥꯛ ꯑꯁꯤ ꯂꯧꯕꯥ ꯃꯇꯃꯗꯥ ꯋꯥꯈꯂꯗꯥ ꯊꯃꯒꯗꯕꯥ ꯋꯥꯐꯃꯁꯤꯡ꯫
- ꯆꯥꯡ ꯅꯥꯏꯅꯥ ꯆꯦꯛ-ꯑꯞ ꯇꯧꯕꯥ: ꯅꯍꯥꯛꯀꯤ ꯗꯣꯛꯇꯔꯒꯤ ꯀ꯭ꯂꯤꯅꯤꯛ ꯑꯦꯄꯣꯏꯟꯇꯃꯦꯟꯇꯁꯤꯡ ꯂꯧꯔꯣꯏꯗꯕꯅꯤ꯫ ꯅꯍꯥꯛꯀꯤ ꯄ꯭ꯔꯣꯒ꯭ꯔꯦꯁ ꯑꯗꯨ ꯌꯦꯡꯁꯤꯅꯕꯥ ꯑꯁꯤ ꯌꯥꯝꯅꯥ ꯃꯔꯨꯑꯣꯏ꯫
- HbA1C ꯇꯦꯁ꯭ꯠ: ꯃꯁꯤ ꯍꯧꯈꯤꯕꯥ ꯊꯥ 2-3ꯒꯤ ꯃꯅꯨꯡꯗꯥ ꯅꯍꯥꯛꯀꯤ ꯗꯥꯏꯑꯦꯕꯦꯇꯤꯖ ꯑꯗꯨ ꯀꯌꯥꯝ ꯐꯖꯅꯥ ꯀꯟꯠꯔꯣꯜ ꯇꯧꯈꯤꯕꯒꯦ ꯍꯥꯌꯕꯗꯨ ꯎꯠꯂꯤꯕꯥ ꯏꯆꯝ ꯆꯝꯕꯥ ꯕ꯭ꯂꯗ ꯇꯦꯁ꯭ꯠ ꯑꯃꯅꯤ꯫
- ꯕ꯭ꯂꯗ ꯁꯨꯒꯔꯒꯤ ꯆꯥꯡ ꯂꯦꯄꯊꯣꯀꯄꯥ: ꯅꯍꯥꯛꯀꯤ ꯕ꯭ꯂꯗ ꯁꯨꯒꯔꯒꯤ ꯆꯥꯡ ꯑꯗꯨ ꯌꯨꯃꯗꯥ ꯀꯔꯝꯅꯥ ꯂꯦꯄꯀꯗꯒꯦ ꯍꯥꯌꯕꯗꯨ ꯈꯪꯖꯤꯅꯕꯤꯌꯨ꯫ ꯕ꯭ꯂꯗ ꯁꯨꯒꯔ ꯅꯦꯝꯕꯥ (ꯍꯥꯏꯄꯣꯒ꯭ꯂꯥꯏꯁꯦꯃꯤꯌꯥ) ꯑꯃꯁꯨꯡ ꯕ꯭ꯂꯗ ꯁꯨꯒꯔ ꯋꯥꯡꯕꯥ (ꯍꯥꯏꯄꯥꯔꯒ꯭ꯂꯥꯏꯁꯦꯃꯤꯌꯥ)ꯒꯤ ꯂꯥꯏꯑꯣꯡꯁꯤꯡ ꯑꯃꯁꯨꯡ ꯃꯈꯣꯌꯗꯨꯒꯤ ꯃꯇꯥꯡꯗꯥ ꯀꯔꯤ ꯇꯧꯒꯗꯒꯦ ꯍꯥꯌꯕꯗꯨ ꯈꯪꯖꯤꯅꯕꯤꯌꯨ꯫
- ꯃꯅꯥꯛ ꯅꯀꯄꯗꯥ ꯂꯩꯕꯥ ꯃꯆꯤ ꯑꯣꯏꯕꯥ ꯆꯤꯟꯖꯥꯛ ꯑꯃꯥ ꯊꯝꯃꯨ: ꯀꯔꯤꯒꯨꯝꯕꯥ ꯅꯍꯥꯛꯅꯥ ꯕ꯭ꯂꯗ ꯁꯨꯒꯔ ꯍꯟꯊꯕꯒꯤ ꯂꯥꯏꯑꯣꯡꯁꯤꯡ ꯎꯔꯕꯗꯤ ꯃꯇꯝ ꯄꯨꯝꯅꯃꯛꯇꯥ ꯊꯨꯅꯥ ꯆꯥꯅꯕꯥ ꯄꯣꯠꯁꯛ ꯑꯃꯥ (ꯈꯨꯗꯝ ꯑꯣꯏꯅꯥ, ꯆꯤꯅꯤꯒꯤ ꯀ꯭ꯌꯨꯕꯁꯤꯡ, ꯇꯣꯐꯤ, ꯒ꯭ꯂꯨꯀꯣꯖ ꯇꯦꯕ꯭ꯂꯦꯇꯁꯤꯡ) ꯃꯅꯥꯛ ꯅꯀꯄꯗꯥ ꯊꯝꯃꯨ꯫
- ꯆꯥꯅꯕꯥ ꯆꯤꯟꯖꯥꯛ ꯊꯥꯗꯣꯛꯂꯣꯏꯗꯕꯅꯤ: ꯃꯇꯝ ꯆꯥꯅꯥ ꯆꯥꯕꯥ꯫
- ꯑꯥꯏꯗꯦꯟꯇꯤꯐꯤꯀꯦꯁꯟ ꯀꯥꯔꯗ ꯑꯃꯥ: ꯅꯍꯥꯛ ꯑꯁꯤ ꯗꯥꯏꯑꯦꯕꯦꯇꯤꯖ ꯂꯩꯔꯦ ꯍꯥꯌꯅꯥ ꯇꯥꯀꯄꯥ ꯀꯥꯔꯗ ꯅꯠꯠꯔꯒꯥ ꯕ꯭ꯔꯦꯁꯂꯦꯠ ꯑꯃꯥ ꯊꯝꯕꯥ ꯑꯃꯁꯨꯡ ꯅꯍꯥꯛꯅꯥ ꯂꯧꯔꯤꯕꯥ ꯏꯅꯁꯨꯂꯤꯅꯒꯤ ꯃꯈꯜ ꯑꯃꯁꯨꯡ ꯗꯣꯖ ꯑꯁꯤ ꯑꯦꯃꯔꯖꯦꯟꯁꯤ ꯑꯃꯗꯥ ꯌꯥꯝꯅꯥ ꯃꯔꯨꯑꯣꯏ꯫
ꯌꯥꯝꯅꯥ ꯃꯔꯨꯑꯣꯏ: ꯅꯍꯥꯛꯀꯤ ꯏꯅꯁꯨꯂꯤꯟ ꯄꯦꯟ ꯅꯠꯠꯔꯒꯥ ꯀꯥꯔꯗ ꯑꯗꯨ ꯀꯩꯗꯧꯉꯩꯗꯥ ꯑꯇꯣꯞꯄꯥ ꯃꯤꯑꯣꯏ ꯑꯃꯒꯥ ꯂꯣꯌꯅꯅꯥ ꯁꯦꯌꯔ ꯇꯧꯔꯣꯏꯗꯕꯅꯤ . ꯀꯔꯤꯒꯨꯝꯕꯥ ꯅꯍꯥꯛꯅꯥ ꯅꯤꯗꯜ ꯑꯗꯨ ꯍꯣꯡꯗꯣꯛꯂꯕꯁꯨ, ꯍꯦꯄꯥꯇꯥꯏꯇꯤꯁ ꯅꯠꯠꯔꯒꯥ HIVꯒꯨꯝꯕꯥ ꯈꯨꯗꯣꯡꯊꯤꯅꯤꯉꯥꯏ ꯑꯣꯏꯕꯥ ꯚꯥꯏꯔꯁꯀꯤ ꯂꯥꯌꯅꯥꯁꯤꯡ ꯁꯟꯗꯣꯀꯄꯒꯤ ꯔꯤꯁ꯭ꯛ ꯌꯥꯝꯅꯥ ꯂꯩ꯫
ꯑꯣꯏꯊꯣꯀꯄꯥ ꯌꯥꯕꯥ ꯁꯥꯏꯗ ꯏꯐꯦꯛꯇꯁꯤꯡ ꯑꯗꯨ ꯀꯔꯤꯅꯣ?
ꯍꯤꯗꯥꯛ ꯑꯃꯍꯦꯛꯇꯒꯨꯝꯅꯥ, ꯃꯁꯤꯅꯥ ꯃꯤꯑꯣꯏ ꯈꯔꯗꯗꯤ ꯁꯥꯏꯗ ꯏꯐꯦꯛꯇ ꯊꯣꯀꯍꯅꯕꯥ ꯌꯥꯏ꯫
| ꯁꯥꯏꯗ ꯏꯐꯦꯛꯇꯀꯤ ꯃꯈꯂꯁꯤꯡ꯫ | |
|---|---|
| ꯈꯨꯗꯛꯇꯥ ꯅꯍꯥꯛꯀꯤ ꯗꯣꯛꯇꯔꯗꯥ ꯍꯥꯌꯒꯗꯕꯥ ꯋꯥꯐꯃꯁꯤꯡ꯫ | |
| ꯑꯦꯂꯥꯔꯖꯤꯒꯤ ꯔꯤꯑꯦꯛꯁꯅꯁꯤꯡ꯫ | ꯈꯣꯡ-ꯈꯨꯠ ꯁꯣꯛ-ꯄꯅꯕꯥ, ꯁꯣꯛ-ꯄꯅꯕꯥ, ꯃꯥꯌ, ꯃꯤꯠ, ꯖꯤꯕ ꯅꯠꯠꯔꯒꯥ ꯀꯣꯛ ꯆꯤꯀꯄꯥ꯫ |
| ꯕ꯭ꯂꯗ ꯁꯨꯒꯔ ꯅꯦꯝꯕꯥ (Hypoglycemia) . | ꯈꯣꯟꯖꯦꯜ ꯊꯣꯀꯄꯥ, ꯁ꯭ꯕꯔ ꯍꯣꯅꯕꯥ ꯋꯥꯕꯥ, ꯋꯥꯈꯜ ꯆꯔꯥꯡꯅꯕꯥ, ꯋꯥꯈꯜ ꯅꯨꯡꯉꯥꯏꯇꯕꯥ, ꯋꯥꯈꯜ ꯅꯨꯡꯉꯥꯏꯇꯕꯥ, ꯊꯝꯃꯣꯌꯒꯤ ꯈꯣꯡꯖꯦꯜ ꯌꯥꯡꯅꯥ ꯆꯦꯅꯕꯥ꯫ |
| ꯄꯣꯇꯥꯁꯤꯌꯃꯒꯤ ꯆꯥꯡ ꯅꯦꯝꯕꯥ꯫ | ꯃꯁꯜ ꯁꯣꯟꯊꯕꯥ ꯅꯠꯠꯔꯒꯥ ꯁꯣꯟꯊꯕꯥ, ꯑꯆꯝꯕꯥ ꯋꯥꯠꯄꯥ, ꯍꯥꯔꯇꯀꯤ ꯈꯣꯡꯖꯦꯜ ꯌꯥꯡꯕꯥ꯫ |
| ꯀꯔꯤꯒꯨꯝꯕꯥ ꯃꯍꯧꯁꯥꯅꯥ ꯃꯈꯣꯌ ꯑꯁꯤ ꯌꯥꯝꯅꯥ ꯁꯥꯊꯤꯕꯥ ꯑꯣꯏꯗ꯭ꯔꯕꯗꯤ, ꯑꯗꯨꯕꯨ ꯂꯦꯡꯗꯅꯥ ꯂꯩꯔꯕꯗꯤ ꯅꯍꯥꯛꯀꯤ ꯗꯣꯛꯇꯔꯗꯥ ꯍꯥꯌꯒꯗꯕꯥ ꯋꯥꯐꯃꯁꯤꯡ꯫ | |
| ꯂꯥꯏꯄꯣꯗꯤꯁ꯭ꯠꯔꯣꯐꯤ (lipodystrophy) ꯂꯩꯕꯥ꯫ | ꯈꯣꯡꯒꯤ ꯃꯈꯥꯗꯥ ꯂꯩꯕꯥ ꯇꯤꯁꯨ ꯑꯗꯨ ꯇꯞꯅꯥ ꯇꯞꯅꯥ ꯁꯣꯀꯄꯥ ꯅꯠꯠꯔꯒꯥ ꯏꯅꯖꯦꯀꯁꯟ ꯇꯧꯔꯤꯕꯥ ꯃꯐꯝ ꯑꯗꯨꯗꯥ ꯁꯣꯀꯄꯥ꯫ (ꯃꯁꯤ ꯊꯤꯡꯅꯕꯒꯤꯗꯃꯛ, ꯏꯅꯖꯦꯀꯁꯟ ꯇꯧꯔꯤꯕꯥ ꯃꯐꯝ ꯑꯗꯨ ꯆꯥꯡ ꯅꯥꯏꯅꯥ ꯍꯣꯡꯗꯣꯀꯎ꯫) |
| ꯏꯅꯖꯦꯀꯁꯟ ꯇꯧꯔꯤꯕꯥ ꯃꯐꯝ ꯑꯗꯨꯗꯥ ꯑꯍꯣꯡꯕꯥ ꯂꯥꯀꯄꯥ꯫ | ꯑꯅꯥꯕꯥ, ꯂꯥꯂꯍꯧꯕꯥ ꯅꯠꯠꯔꯒꯥ ꯈꯔꯥ ꯁꯣꯀꯄꯥ꯫ |
| ꯑꯔꯨꯝꯕꯥ ꯍꯦꯅꯒꯠꯂꯀꯄꯥ꯫ | ꯃꯤꯑꯣꯏ ꯈꯔꯗꯤ ꯏꯅꯁꯨꯂꯤꯟ ꯍꯧꯔꯕꯥ ꯃꯇꯨꯡꯗꯥ ꯑꯔꯨꯝꯕꯥ ꯈꯔꯥ ꯍꯦꯅꯒꯠꯂꯀꯄꯥ ꯌꯥꯏ꯫ |
ꯍꯤꯗꯥꯛ-ꯂꯥꯡꯊꯛ ꯑꯁꯤ ꯀꯔꯝꯅꯥ ꯊꯃꯒꯗꯒꯦ?
ꯏꯅꯁꯨꯂꯤꯟ ꯑꯁꯤ ꯃꯑꯣꯡ ꯆꯨꯝꯅꯥ ꯊꯃꯖꯤꯅꯒꯗꯕꯥ ꯍꯤꯗꯥꯛ ꯑꯃꯅꯤ, ꯅꯠꯠꯔꯕꯗꯤ ꯃꯁꯤꯒꯤ ꯏꯐꯦꯛꯇꯤꯕꯅꯦꯁ ꯑꯗꯨ ꯃꯥꯡꯈꯤꯕꯥ ꯌꯥꯏ꯫
ꯑꯍꯥꯡꯕꯥ ꯚꯤꯑꯦꯜ ꯑꯃꯁꯨꯡ ꯄꯦꯅꯁꯤꯡ꯫
- ꯈ꯭ꯕꯥꯏꯗꯒꯤ ꯐꯕꯥ ꯄꯥꯝꯕꯩ: ꯐ꯭ꯔꯤꯖꯔꯒꯤ ꯃꯅꯨꯡꯒꯤ ꯁꯦꯂꯐꯝ ꯑꯃꯗꯥ, ꯊꯣꯡꯅꯥꯎꯗꯥ ꯅꯠꯇꯅꯥ, ꯗꯤꯒ꯭ꯔꯤ ꯁꯦꯂꯁꯤꯌꯁ 2 ꯑꯃꯁꯨꯡ 8ꯒꯤ ꯃꯔꯛꯇꯥ ꯂꯩꯕꯥ ꯇꯦꯝꯄꯦꯔꯦꯆꯔꯗꯥ ꯊꯃꯒꯗꯕꯅꯤ꯫
- ꯑꯇꯣꯞꯄꯥ ꯃꯑꯣꯡ ꯑꯃꯗꯥ: ꯅꯍꯥꯛꯅꯥ ꯔꯨꯝ ꯇꯦꯝꯄꯦꯔꯦꯆꯔꯗꯥ (ꯁꯦꯂꯁꯤꯌꯁ ꯗꯤꯒ꯭ꯔꯤ 30ꯒꯤ ꯃꯈꯥꯗꯥ) ꯊꯃꯖꯤꯅꯕꯁꯨ ꯌꯥꯏ꯫
- ꯀꯩꯗꯧꯉꯩꯗꯥ ꯐ꯭ꯔꯤꯖꯔꯗꯥ ꯊꯃꯒꯅꯨ꯫ ꯐ꯭ꯔꯣꯖꯟ ꯏꯅꯁꯨꯂꯤꯟ ꯁꯤꯖꯤꯟꯅꯒꯅꯨ꯫
- ꯃꯇꯝ ꯂꯣꯌꯔꯕꯥ ꯃꯇꯨꯡꯗꯥ ꯊꯥꯗꯣꯀꯎ꯫
ꯏꯟ-ꯌꯨꯖ ꯚꯤꯑꯦꯜ ꯑꯃꯁꯨꯡ ꯄꯦꯅꯁꯤꯡ꯫
- ꯅꯍꯥꯛꯅꯥ ꯁꯤꯖꯤꯟꯅꯕꯥ ꯍꯧꯔꯀꯄꯥ ꯚꯤꯑꯦꯜ ꯅꯠꯠꯔꯒꯥ ꯄꯦꯟ ꯑꯃꯥ ꯔꯦꯐ꯭ꯔꯤꯖꯔꯦꯇꯔꯗꯥ ꯅꯠꯠꯔꯒꯥ ꯔꯨꯝ ꯇꯦꯝꯄꯦꯔꯦꯆꯔꯗꯥ (ꯁꯦꯂꯁꯤꯌꯁ ꯗꯤꯒ꯭ꯔꯤ 30ꯒꯤ ꯃꯈꯥꯗꯥ) ꯊꯝꯕꯥ ꯌꯥꯏ꯫
- ꯈ꯭ꯕꯥꯏꯗꯒꯤ ꯃꯔꯨꯑꯣꯏꯕꯗꯤ: ꯃꯁꯤ ꯑꯍꯥꯅꯕꯥ ꯑꯣꯏꯅꯥ ꯁꯤꯖꯤꯟꯅꯔꯕꯥ ꯃꯇꯨꯡ ꯅꯨꯃꯤꯠ 56 (ꯅꯨꯃꯤꯠ 8)ꯒꯤ ꯃꯅꯨꯡꯗꯥ ꯊꯥꯗꯣꯛꯀꯗꯕꯅꯤ꯫ ꯃꯅꯨꯡꯗꯥ ꯏꯅꯁꯨꯂꯤꯟ ꯑꯃꯠꯇꯥ ꯂꯩꯠꯔꯕꯗꯤ ꯃꯗꯨ ꯈꯖꯤꯛꯇꯪ ꯊꯥꯗꯣꯀꯎ꯫
- ꯍꯀꯊꯦꯡꯅꯅꯥ ꯅꯨꯃꯤꯠꯀꯤ ꯃꯉꯥꯜ ꯑꯃꯁꯨꯡ ꯑꯀꯅꯕꯥ ꯑꯁꯥꯕꯥ ꯏꯁꯤꯡꯗꯒꯤ ꯂꯥꯞꯅꯥ ꯂꯩꯌꯨ꯫
ꯇꯦꯛ-ꯍꯣꯝ ꯃꯦꯁꯦꯖ ꯇꯧꯕꯥ꯫
- ꯏꯅꯁꯨꯂꯤꯟ ꯗꯦꯒ꯭ꯂꯨꯗꯦꯛ ꯑꯁꯤ ꯃꯇꯝ ꯁꯥꯡꯅꯥ ꯊꯕꯛ ꯇꯧꯕꯥ ꯏꯅꯁꯨꯂꯤꯟ ꯑꯃꯅꯤ꯫ ꯃꯁꯤ ꯆꯞ ꯃꯥꯟꯅꯕꯥ ꯁꯤꯔꯤꯟꯖꯗꯥ ꯑꯇꯣꯞꯄꯥ ꯃꯈꯂꯒꯤ ꯏꯅꯁꯨꯂꯤꯅꯁꯤꯡꯒꯥ ꯂꯣꯌꯅꯅꯥ ꯌꯥꯟꯁꯤꯟꯅꯒꯅꯨ꯫
- ꯏꯅꯁꯨꯂꯤꯟ ꯁꯣꯜꯌꯨꯁꯟ ꯑꯗꯨ ꯁꯤꯖꯤꯟꯅꯗ꯭ꯔꯤꯉꯩ ꯃꯃꯥꯡꯗꯥ ꯃꯇꯝ ꯄꯨꯝꯅꯃꯛꯇꯥ ꯃꯌꯦꯛ ꯁꯦꯡꯕꯥ ꯑꯃꯁꯨꯡ ꯃꯆꯨ ꯂꯩꯇꯕꯥ ꯑꯣꯏꯕ꯭ꯔꯥ ꯍꯥꯌꯕꯗꯨ ꯆꯦꯛ ꯇꯧ꯫
- ꯕ꯭ꯂꯗ ꯁꯨꯒꯔ ꯅꯦꯝꯕꯥ (ꯍꯥꯏꯄꯣꯒ꯭ꯂꯥꯏꯁꯦꯃꯤꯌꯥ)ꯒꯤ ꯂꯥꯏꯑꯣꯡꯁꯤꯡ ꯈꯪꯖꯤꯅꯒꯗꯕꯅꯤ ꯑꯃꯁꯨꯡ ꯃꯇꯝ ꯄꯨꯝꯅꯃꯛꯇꯥ ꯃꯆꯤ ꯑꯣꯏꯕꯥ ꯆꯤꯟꯖꯥꯛ ꯑꯃꯥ ꯃꯅꯥꯛ ꯅꯀꯄꯗꯥ ꯊꯃꯒꯗꯕꯅꯤ꯫
- ꯅꯍꯥꯛꯀꯤ ꯏꯅꯁꯨꯂꯤꯟ ꯄꯦꯟ ꯅꯠꯠꯔꯒꯥ ꯅꯤꯗꯂꯁꯤꯡ ꯑꯗꯨ ꯀꯩꯗꯧꯉꯩꯗꯥ ꯑꯇꯣꯞꯄꯁꯤꯡꯗꯥ ꯁꯦꯌꯔ ꯇꯧꯔꯣꯏꯗꯕꯅꯤ꯫
- ꯏꯅꯁꯨꯂꯤꯟ ꯑꯗꯨ ꯃꯑꯣꯡ ꯆꯨꯝꯅꯥ ꯁ꯭ꯇꯣꯔ ꯇꯧ꯫ ꯅꯨꯃꯤꯠ 56ꯅꯤ ꯁꯤꯖꯤꯟꯅꯔꯕꯥ ꯃꯇꯨꯡꯗꯥ ꯊꯥꯗꯣꯀꯎ꯫
- ꯀꯔꯤꯒꯨꯝꯕꯥ ꯅꯍꯥꯛꯅꯥ ꯍꯤꯗꯥꯛ ꯑꯁꯤꯒꯤ ꯃꯇꯥꯡꯗꯥ ꯋꯥꯈꯜ ꯋꯥꯕꯥ ꯅꯠꯠꯔꯒꯥ ꯋꯥꯍꯪ ꯑꯃꯠꯇꯥ ꯂꯩꯔꯕꯗꯤ, ꯅꯍꯥꯛꯀꯤ ꯗꯣꯛꯇꯔꯒꯥ ꯇꯥꯟꯅꯧ꯫
💬 Comments (0)
No comments yet. Be the first to share your thoughts here.
Add Your Comment